Fgfr3 Fusion Gene And Pharmaceutical Drug Targeting Same

Patent No. EP2902489 (titled "Fgfr3 Fusion Gene And Pharmaceutical Drug Targeting Same") was filed by Chugai Seiyaku Kabushiki Kaisha on Sep 27, 2013. The application was issued on Feb 7, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MURPHYJun 13, 2018COOLEY UK

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2902489

CHUGAI SEIYAKU KABUSHIKI KAISHA
Application Number
EP13842962A
Filing Date
Sep 27, 2013
Status
Granted And Under Opposition
Aug 11, 2017
Publication Date
Feb 7, 2018